CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl, Philipp Wendel, Ralf Schubert, Emilia Salzmann‐Manrique, Ivana von Metzler, Toni Cathomen, Evelyn Ullrich

OncoImmunology · 2022 · 77 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

-editing in primary NK cells has the prospect of overcoming immune checkpoint inhibition in clinical applications.

References

9